Restoration® Modular Revision Hip System Post Market Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00962013
Recruitment Status : Completed
First Posted : August 19, 2009
Results First Posted : August 15, 2014
Last Update Posted : March 29, 2017
Information provided by (Responsible Party):
Stryker Orthopaedics

Brief Summary:
The purpose of this study is to demonstrate survivorship of the femoral stem at 5 years.

Condition or disease Intervention/treatment Phase
Arthroplasty, Replacement, Hip Device: Restoration® Modular Revision Hip System Not Applicable

Detailed Description:

The two-piece modular revision stem components are intended to be used for primary or revision total hip arthroplasty, as well as in the presence of severe proximal bone loss. This study evaluates the System in revision cases only. The stems are intended to be used with Stryker Orthopaedics femoral heads, unipolar and bipolar components, and acetabular components. These femoral stems are designed to be press fit into the proximal femur.

In addition to demonstrating survivorship at 5 years, this study will seek to gain information on four secondary objectives: radiographic stability, Harris Hip Scores, SF-36 general well-being assessment, and safety profile.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 137 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Prospective Open-Label Evaluation of the Restoration® Modular System
Study Start Date : January 2004
Actual Primary Completion Date : December 2011
Actual Study Completion Date : December 2011

Arm Intervention/treatment
Restoration® Modular
All subjects were enrolled into a single arm and received the Restoration® Modular Revision Hip System to replace the femoral portion of a failed previous implant.
Device: Restoration® Modular Revision Hip System
Restoration® Modular Revision System

Primary Outcome Measures :
  1. Stem Survivorship (%) [ Time Frame: 5 years ]
    Failure is defined by stem revision for any cause.

  2. Femoral Stem Fracture [ Time Frame: 5 years ]

Secondary Outcome Measures :
  1. Radiographic Stability [ Time Frame: 5 years ]
    Absence of a radiolucent lines ≥ 2mm around the entire stem in AP or ML view.

  2. Harris Hip Score [ Time Frame: pre-op and 5 years ]

    Scores can range from 0 to 100 with 0 being the worst and 100 being the best score. A score of 80-100 is considered good-excellent and a score less than or equal to 79 is considered fair-poor.

    90 - 100 = excellent

    80 - 89 = good

    70 - 79 = fair

    0 - 69 = poor

  3. SF-36 Health Status Survey: Role - Physical [ Time Frame: pre-op, 2 year and 5 year ]

    Consists of 8 subscores all with a range of 0-100; a higher score indicates a better health state:

    The subscores are: 1 - Physical Functioning, 2 - Role-Physical, 3 - Bodily Pain, 4 - General Health, 5 - Vitality, 6 - Social Functioning, 7- Role-Emotional, 8 - Mental Health

    This Secondary Outcome Measure is focused on the "Role-Physical" score.

  4. Post-surgery Femoral Crack/Fracture and Subsidence Rate [ Time Frame: Post-op to 5 years ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Candidates for cementless revision of a failed femoral prosthesis.
  • Patients willing to sign the informed consent.
  • Patients able to comply with follow-up requirements including post-operative weightbearing restrictions and self-evaluations.
  • Male and non-pregnant female patients ages 18 to 85 years of age at the time of surgery.

Exclusion Criteria:

  • Patients with ongoing infection.
  • Patients who are severely immunocompromised.
  • Patients who are prisoners.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00962013

United States, California
Orthopaedic Specialty Institute
Orange, California, United States, 92868
United States, Iowa
Iowa Orthopaedic Center
Des Moines, Iowa, United States, 50314
United States, Kansas
Kansas Joint and Spine Institute
Wichita, Kansas, United States, 67226
United States, Kentucky
Jewish Hospital Center for Advanced Medicine
Louisville, Kentucky, United States, 40202
United States, Nebraska
New West Sports Medicine and Orthopaedic Surgery
Kearney, Nebraska, United States, 68847
United States, New York
Hospital for Joint Diseases
New York, New York, United States, 10003
Beth Israel Medical Center
New York, New York, United States, 10021
United States, Ohio
Crystal Clinic
Akron, Ohio, United States, 44333
United States, Oregon
Providence Portland Medical Center
Portland, Oregon, United States, 97213
United States, Pennsylvania
Rothman Institute
Philadelphia, Pennsylvania, United States, 19107
United States, Texas
Orthopedic Associates of Corpus Christi
Corpus Christi, Texas, United States, 78411
Scott and White Hospital
Temple, Texas, United States, 76508
United States, Washington
Providence Orthopaedic Specialities
Spokane, Washington, United States, 99204
Sponsors and Collaborators
Stryker Orthopaedics
Principal Investigator: Steven Barnett, MD Orthopaedic Specialty Institute
Principal Investigator: Michael W Britt, MD Orthopaedic Associates of Corpus Christi
Principal Investigator: Kenneth A Greene, MD Crystal Clinic
Principal Investigator: Steven F Harwin, MD Beth Israel Medical Center
Principal Investigator: D. Christopher Hikes, MD Providence Health & Services
Principal Investigator: Kirby Hitt, MD Scott and White Hospital
Principal Investigator: William Hozack, md Rothman Institute
Principal Investigator: Frederick Jaffe, MD Hospital for Joint Diseases
Principal Investigator: Timothy P Lovell, MD Providence Orthopaedic Specialties
Principal Investigator: Mark R Matthes, MD Iowa Orthopaedic Center
Principal Investigator: Arthur Malkani, MD Jewish Hospital Center for Advanced Medicine
Principal Investigator: John Schurman, MD Kansas Joint and Spine Institute
Principal Investigator: John Wright, MD New West Sports Medicine and Orthopaedic Surgery

Responsible Party: Stryker Orthopaedics Identifier: NCT00962013     History of Changes
Other Study ID Numbers: 53
First Posted: August 19, 2009    Key Record Dates
Results First Posted: August 15, 2014
Last Update Posted: March 29, 2017
Last Verified: February 2017